Rockwell Medical, Inc. (RMTI)

Rockwell Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.39	15.66	8.98	10.1	13.28	48.68
Short-Term Investments	5.94	5.94	1.95	11.39	9.16	10
Cash & Short-Term Investments	17.33	21.6	10.94	21.49	22.44	58.68
Cash Growth	101.08%	97.55%	-49.12%	-4.22%	-61.76%	125.30%
Accounts Receivable	9.67	8.29	10.9	6.26	5.91	4.17
Receivables	9.67	8.29	10.9	6.26	5.91	4.17
Inventory	5.05	5.78	5.87	5.81	4.08	3.91
Prepaid Expenses	0.99	1.36	1.06	1.75	2.86	2.71
Total Current Assets	33.03	37.03	28.77	35.31	35.29	69.47
Property, Plant & Equipment	9.42	10.34	11.02	8.61	10.22	5.55
Goodwill	0.92	0.92	0.92	0.92	0.92	0.92
Other Intangible Assets	10.07	10.21	10.76	-	-	-
Other Long-Term Assets	0.52	0.71	0.71	1.8	2.14	1.81
Total Assets	53.96	59.21	52.17	46.64	48.57	77.75
Accounts Payable	1.93	2.87	4.52	4.05	3.74	4.16
Accrued Expenses	3.28	4.86	5.49	7.12	4.29	4.26
Short-Term Debt	0.07	0.27	0.24	0.5	0.44	-
Current Portion of Long-Term Debt	-	-	-	1.63	7.38	-
Current Portion of Leases	2.07	2.17	1.94	2.01	2	1.17
Current Unearned Revenue	2.57	2.51	2.79	1.8	2.32	2.33
Other Current Liabilities	1.29	1.42	1.66	0.59	0.8	0.89
Total Current Liabilities	11.21	14.09	16.64	17.69	20.97	12.79
Long-Term Debt	8.56	8.47	8.29	7.56	13.19	20.95
Long-Term Leases	2.18	2.63	2.96	4.67	5.89	1.82
Long-Term Unearned Revenue	0.5	1.43	2.98	2.6	5.99	8.02
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	-
Total Liabilities	22.44	26.62	30.88	32.53	46.04	43.58
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	430.65	430.21	418.49	402.7	372.56	371.51
Retained Earnings	-399.19	-397.68	-397.2	-388.76	-370.08	-337.41
Comprehensive Income & Other	0.06	0.05	-0	0.16	0.05	0.06
Shareholders' Equity	31.52	32.59	21.29	14.11	2.54	34.17
Total Liabilities & Equity	53.96	59.21	52.17	46.64	48.57	77.75
Total Debt	12.87	13.54	13.44	16.36	28.9	23.94
Net Cash (Debt)	4.46	8.07	-2.5	5.13	-6.46	34.74
Net Cash Growth	-	-	-	-	-	57.86%
Net Cash Per Share	0.14	0.26	-0.11	0.36	-0.76	5.05
Filing Date Shares Outstanding	34.17	34.06	29.33	12.55	8.54	8.51
Total Common Shares Outstanding	34.26	34.06	29.13	12.16	8.54	8.51
Working Capital	21.83	22.94	12.13	17.62	14.32	56.68
Book Value Per Share	0.92	0.96	0.73	1.16	0.30	4.02
Tangible Book Value	20.53	21.46	9.61	13.19	1.61	33.25
Tangible Book Value Per Share	0.60	0.63	0.33	1.08	0.19	3.91
Machinery	14.55	14.63	13.78	8.57	8.39	7.98
Leasehold Improvements	1.56	1.56	1.42	1.26	1.2	1.2

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q